ArticleBMC cancer2022

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth.

Sayani Bhattacharjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.